Accuray Receives IMV Award for Best In Service in Radiation Oncology for 2022 Read more about Accuray Receives IMV Award for Best In Service in Radiation Oncology for 2022
Oscar Lambret Center in France Installs Second Accuray Radixact® System, the Hospital's Fifth Accuray Radiation Therapy Delivery System Read more about Oscar Lambret Center in France Installs Second Accuray Radixact® System, the Hospital's Fifth Accuray Radiation Therapy Delivery System
Accuray Reports Fiscal 2023 First Quarter Financial Results Read more about Accuray Reports Fiscal 2023 First Quarter Financial Results
Accuray Announces Tomo® C Registration Submission to China's National Medical Products Administration Read more about Accuray Announces Tomo® C Registration Submission to China's National Medical Products Administration
New Reimbursement Approved by the Japanese Ministry of Health, Labor and Welfare for the Accuray CyberKnife® System to Treat Trigeminal Neuralgia, a Condition Often Causing Severe Facial Pain Read more about New Reimbursement Approved by the Japanese Ministry of Health, Labor and Welfare for the Accuray CyberKnife® System to Treat Trigeminal Neuralgia, a Condition Often Causing Severe Facial Pain
GE Healthcare and Accuray Collaborate to Expand Access, Advance the Practice of Precision Radiation Therapy Read more about GE Healthcare and Accuray Collaborate to Expand Access, Advance the Practice of Precision Radiation Therapy
Accuray to Report First Quarter Fiscal 2023 Financial Results on November 2, 2022 Read more about Accuray to Report First Quarter Fiscal 2023 Financial Results on November 2, 2022
Accuray and C-RAD Unveil Automated Breast Cancer Treatment Package for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual Meeting Read more about Accuray and C-RAD Unveil Automated Breast Cancer Treatment Package for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual Meeting
Data Published in The Lancet Oncology Indicate Men With Prostate Cancer Treated With the Accuray CyberKnife® Platform Experienced a Lower Incidence of Bladder Side Effects Than Those Treated With Conventional Linear Accelerators Read more about Data Published in The Lancet Oncology Indicate Men With Prostate Cancer Treated With the Accuray CyberKnife® Platform Experienced a Lower Incidence of Bladder Side Effects Than Those Treated With Conventional Linear Accelerators
Accuray to Host Meeting with Analysts and Investors at ASTRO on October 24, 2022 Read more about Accuray to Host Meeting with Analysts and Investors at ASTRO on October 24, 2022
